MOSCOW (Sputnik) – The Russian Health Ministry has authorized phase 1 and 2 clinical trials of EpiVacCorona-N, one more coronavirus vaccine developed by the Vector research center, according to the ministry’s register.
Read More
Indian Crematoriums Overwhelmed as Surge In New COVID-19 Cases Allegedly Underreported, Report Says
...
